ADMA Biologics Inc (ADMA)
Operating return on assets (Operating ROA)
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating income (ttm) | US$ in thousands | 138,983 | 114,893 | 83,940 | 44,266 | 21,632 | 1,340 | -16,662 | -25,364 | -39,366 | -46,498 | -51,618 | -58,024 | -58,373 | -62,402 | -61,766 | -63,309 | -64,915 | -55,522 | -50,771 | -44,986 |
| Total assets | US$ in thousands | 488,678 | 390,618 | 376,399 | 350,875 | 329,182 | 348,997 | 343,027 | 340,788 | 348,461 | 300,558 | 296,932 | 308,032 | 276,253 | 238,640 | 232,814 | 235,667 | 207,673 | 189,976 | 191,542 | 210,524 |
| Operating ROA | 28.44% | 29.41% | 22.30% | 12.62% | 6.57% | 0.38% | -4.86% | -7.44% | -11.30% | -15.47% | -17.38% | -18.84% | -21.13% | -26.15% | -26.53% | -26.86% | -31.26% | -29.23% | -26.51% | -21.37% |
December 31, 2024 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $138,983K ÷ $488,678K
= 28.44%
ADMA Biologics Inc's operating return on assets (operating ROA) shows a gradual improvement over the periods from March 31, 2020, to December 31, 2024. The operating ROA started at a negative 21.37% in March 2020 and declined further to negative 31.26% by December 2020. However, from March 2021 onwards, there was a consistent improvement in the operating ROA, with negative percentages reducing each quarter.
By the end of December 2023, the operating ROA had turned positive, standing at 6.57%. This positive trend continued into the next period, with operating ROA reaching 12.62% by March 31, 2024. The improvement accelerated in the subsequent quarters, with operating ROA peaking at 29.41% by September 30, 2024, before stabilizing slightly at 28.44% by the end of December 2024.
Overall, the trend in operating ROA indicates that ADMA Biologics Inc's operational efficiency and profitability in generating income from its assets improved significantly over the analyzed period, reflecting a positive trajectory for the company's financial performance.
Peer comparison
Dec 31, 2024